Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 37
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | van Schalkwyk J, Nourmoussavi M, Massey A, Gustafson R, Brodkin E, Petric M, Krajden M, Dobson S, Buxton J, Bigham M, Pick N, Schreiber R, Sherlock CH, Money D, Yoshida EM | 2014 | Can J Gastroenterol Hepatol | View Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | Health care providers | Clinical research |
New cancers after autotransplantations for multiple myeloma | Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN | 2015 | Biol Blood Marrow Transplant | View New cancers after autotransplantations for multiple myeloma | Health care providers | Clinical research |
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Zeller M, Arnold DM | 2015 | Am J Hematol | View Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Health care providers | Clinical research |
Using pharmacokinetics to individualize hemophilia therapy | Iorio A | 2017 | Hematology Am Soc Hematol Educ Program | View Using pharmacokinetics to individualize hemophilia therapy | Health care providers | Clinical research |
Within-individual mean corpuscular volume variation | Cembrowski G, Topping K, Clarke G | 2014 | Arch Pathol Lab Med | View Within-individual mean corpuscular volume variation | Health care providers | Other |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Rh System: Anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-V | Health care providers | Benchmarking and standard setting |
Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Morin P-A, Skeate R, Clarke G | 2020 | Blood.ca website | View Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice | Health care providers | Benchmarking and standard setting |
The unique characteristics of COVID-19 coagulopathy | Iba T, Levy J, Conors J, Warkentin T, Tachil J, Levi M | 2020 | Crit Care | View The unique characteristics of COVID-19 coagulopathy | Health care providers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, He?imovi? A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Health care providers | Benchmarking and standard setting |
Transfusion-Transmitted Infections | Drews SJ, Dodd RY | 2022 | Practical Transfusion Medicine | View Transfusion-Transmitted Infections | Health care providers | Benchmarking and standard setting |
Transfusion camp: A retrospective study of self-reported impact on postgraduate trainee transfusion practice | Yeung KCY, Kapitany C, Chargé S, Callum J, Cserti-Gazdewich C, D'Empaire PP, Khandelwal A, Lieberman L, Lee C, Pavenski K, Pendergrast J, Shehata N, Hsia CC, Lavoie M, Murphy MF, Prokopchuk-Gauk O, Rahmani M, Trudeau J, Zeller MP, Lin Y | 2023 | Transfusion | View Transfusion camp: A retrospective study of self-reported impact on postgraduate trainee transfusion practice | Health care providers | Education research |
Acute megakaryoblastic transformation from essential thrombocythemia | Roshan TM, Rajput AB, Berardi P, Padmore R | 2017 | Hum Pathol | View Acute megakaryoblastic transformation from essential thrombocythemia | Health care providers | Clinical research |
An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study | Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, Elahie A, Garritsen H, Hancock H, Kutner JM, Manukian B, Mizuta S, Okuda M, Pagano MB, Poglod R, Rushford K, Selleng K, Sorensen CH, Sprogoe U, Staves J, Weiland T, Wendel S, Wood EM, van de Watering L, van Wordragen-Vlaswinkel M, Ziman A, Jan Zwaginga J, Murphy MF, Heddle NM, Yazer MH | 2017 | Transfusion | View An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study | Health care providers | Clinical research |
Association of blood donor age and sex with recipient survival after red blood cell transfusion | Chassé M, Tinmouth A, English SW, Acker JP, Wilson K, Knoll G, Shehata N, Van Walraven C, Forster A, Ramsay T, McIntyre L, Fergusson DA | 2016 | JAMA Intern Med | View Association of blood donor age and sex with recipient survival after red blood cell transfusion | Health care providers | Clinical research |
Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Health care providers | Benchmarking and standard setting |
Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood | Pai M, Cook R, Barty R, Eikelboom J, Lee KA, Heddle N | 2016 | Transfusion | View Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood | Health care providers | Clinical research |
Molecular immunohematology at Canadian Blood Services: red cell antigen genotyping | Goldman M, Hannaford K, Hannon J, Berardi P | 2016 | Blood.ca website | View Molecular immunohematology at Canadian Blood Services: red cell antigen genotyping | Health care providers | Other |
Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Alam A, Huang M, Yi Q-L, Lin Y, Hannach B | 2014 | Transfus Apher Sci | View Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Health care providers | Other |
Platelet transfusion: a systematic review of the clinical evidence | Kumar A, Mhaskar R, Grossman BJ, Kaufman RM, Tobian AA, Kleinman S, Gernsheimer T, Tinmouth AT, Djulbegovic B | 2015 | Transfusion | View Platelet transfusion: a systematic review of the clinical evidence | Health care providers | Clinical research |
Problems with precaution: the transfusion medicine experience | Wilson K, Atkinson KM, Fergusson DA, Brown A, Forster A, Murphy MS, Tinmouth AT, Keelan J | 2017 | J Risk Res | View Problems with precaution: the transfusion medicine experience | Health care providers | Ethical, legal and social implications research |
Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Fearon M, Scalia V, Lane D, Bigham M, Hawes G, O'Brien S, Kadkhoda K | 2016 | Transfusion | View Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Health care providers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2014 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Transfusion-related acute lung injury (TRALI) | Petraszko T | 2017 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Health care providers | Other |
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Cohen R, Ning S, Yan MTS, Callum J | 2018 | Transfus Med Rev | View Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
A case of recurrent transfusion-related acute lung injury despite lessons learned from antibody mitigation | McVey MJ, Lin Y, Young DK, Cserti-Gazdewich C | 2019 | Transfus Med | View A case of recurrent transfusion-related acute lung injury despite lessons learned from antibody mitigation | Health care providers | Clinical research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries | Bloch EM, Goel R, Montemayor C, Cohn C, Tobian AAR | 2020 | Transfus Apher Sci | View Promoting access to COVID-19 convalescent plasma in low- and middle-income countries | Health care providers | Clinical research |
Whole Blood and Apheresis Collection of Blood Components Intended for Transfusion | Acker J, Razatos A | 2020 | AABB Technical Manual, 20th Edition | Health care providers | Benchmarking and standard setting | |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Health care providers | Clinical research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Health care providers | Benchmarking and standard setting |
Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Okello CD, Shih AW, Angucia B, Kiwanuka N, Heddle N, Orem J, Mayanja-Kizza H | 2022 | PLoS One | View Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Health care providers | Clinical research |
Circular of information for the use of human blood components: Platelets | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia | Bryant A, Sheppard D, Sabloff M, Delbaere M, Maze R, Allan D, Atkins H, Bence-Bruckler I, Faught C, Huebsch L, Tay J, Zanke B, Bredeson C | 2015 | Leuk Lymphoma | View A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia | Health care providers | Clinical research |
Airway Compromise and Perioperative Management of a Patient with Acquired Factor XIII Inhibitor | Tone K, Lalu M, Kilty SJ, Rosenberg E, Tinmouth A | 2015 | A&A Case Reports | View Airway Compromise and Perioperative Management of a Patient with Acquired Factor XIII Inhibitor | Health care providers | Clinical research |
Bacterial Contamination | Ramirez-Arcos S, Goldman M | 2017 | Practical Transfusion Medicine, 5th Edition | View Bacterial Contamination | Health care providers | Benchmarking and standard setting |
Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia | Nazi I, Arnold DM, Warkentin TE, Smith JW, Staibano P, Kelton JG | 2015 | J Thromb Haemost | View Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia | Health care providers | Clinical research |
Multicountry survey of emergency and critical care medicine physicians' fluid resuscitation practices for adult patients with early septic shock | McIntyre L, Rowe BH, Walsh TS, Gray A, Arabi Y, Perner A, Gordon A, Marshall J, Cook D, Fox-Robichaud A, Bagshaw SM, Green R, Schweitzer I, Turgeon A, Zarychanski R, English S, Chassé M, Stiell I, Fergusson D | 2016 | BMJ Open | View Multicountry survey of emergency and critical care medicine physicians' fluid resuscitation practices for adult patients with early septic shock | Health care providers | Clinical research |
Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture | Rempel S, Murti M, Buxton J, Stephens W, Watterson M, Andonov A, Fung C, Ramler G, Bigham M, Lem M | 2016 | Canada Communicable Disease Report | View Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture | Health care providers | Clinical research |
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia | Nazi I, Kelton JG, Larche M, Snider DP, Heddle NM, Crowther MA, Cook RJ, Tinmouth AT, Mangel J, Arnold DM | 2013 | Blood | View The effect of rituximab on vaccine responses in patients with immune thrombocytopenia | Health care providers | Clinical research |
Thrombotic microangiopathies: a general approach to diagnosis and management | Arnold D, Patriquin C, Nazy I | 2017 | CMAJ | View Thrombotic microangiopathies: a general approach to diagnosis and management | Health care providers | Clinical research |
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Spaner DE, Venema R, Huang J, Norris P, Lazarus A, Wang G, Shi Y | 2018 | EBioMedicine | View Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Health care providers | Clinical research |